ASSET PURCHASE AGREEMENT by and between ACTELION PHARMACEUTICALS LTD. and VANDA PHARMACEUTICALS INC. DATED AS OF DECEMBER 7, 2023Asset Purchase Agreement • February 8th, 2024 • Vanda Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 8th, 2024 Company Industry JurisdictionThis Asset Purchase Agreement, dated as of December 7, 2023, is made by and between Actelion Pharmaceuticals Ltd., a limited liability company organized under the laws of Switzerland (“Seller”), and Vanda Pharmaceuticals Inc., a Delaware corporation (“Purchaser”).